The pharmaceutical industry is defined by constant change and evolution.
This ever-changing nature of the industry, driven primarily by advances in therapies, medical devices and disease management, creates a constant demand for Pharma companies to educate healthcare professionals (HCPs), ensuring scientific data is accessible and accurately interpreted.
A major part of this education effort is taken on by Key Opinion Leaders (KOLs) - highly
respected experts in a particular therapeutic area or segment of the industry, who support the dissemination of scientific information and drug innovations to their HCP peers, which is a fundamental activity for the continued improvement of patient treatment and health outcomes.